These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35409062)

  • 1. A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.
    Fiscon G; Conte F; Farina L; Paci P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAveRUNNER: an R-based tool for drug repurposing.
    Fiscon G; Paci P
    BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
    Chen HR; Sherr DH; Hu Z; DeLisi C
    BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based approach for drug repurposing against mpox.
    Tang K; Sun Q; Zeng J; Tang J; Cheng P; Qiu Z; Long H; Chen Y; Zhang C; Wei J; Qiu X; Jiang G; Fang Q; Sun L; Sun C; Du X
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132468. PubMed ID: 38761900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential of drug repurposing for liver diseases: A comprehensive study.
    Ali FEM; Abdel-Reheim MA; Hassanein EHM; Abd El-Aziz MK; Althagafy HS; Badran KSA
    Life Sci; 2024 Jun; 347():122642. PubMed ID: 38641047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A machine learning and network framework to discover new indications for small molecules.
    Gilvary C; Elkhader J; Madhukar N; Henchcliffe C; Goncalves MD; Elemento O
    PLoS Comput Biol; 2020 Aug; 16(8):e1008098. PubMed ID: 32764756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
    Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
    Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches in identification of a novel drug targets for drug repurposing.
    Khambhati K; Singh V
    Prog Mol Biol Transl Sci; 2024; 205():213-220. PubMed ID: 38789179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational biology approaches for drug repurposing.
    Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia.
    Koch E; Kauppi K; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110637. PubMed ID: 36099967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMSDR: Drug repurposing approach based on transcriptome data and network module similarity.
    Ünsal Ü; Cüvitoğlu A; Turhan K; Işık Z
    Mol Inform; 2023 Mar; 42(3):e2200077. PubMed ID: 36411244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules.
    Unal U; Gov E
    Cancer Invest; 2023 Sep; 41(8):713-733. PubMed ID: 37682113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network neighborhood operates as a drug repositioning method for cancer treatment.
    Cüvitoğlu A; Isik Z
    PeerJ; 2023; 11():e15624. PubMed ID: 37456868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.